Neuroimaging statistical approaches for determining neural correlates of Alzheimer's disease via positron emission tomography imaging
Authors:
- Daniel F. DrakeDDDaniel F. Drake
- Gordana DeradoGDGordana Derado
- Lijun ZhangLZLijun Zhang
- F. DuBois BowmanFBF. DuBois Bowman
- For The Alzheimer'S Disease Neuroimaging InitiativeFIFor The Alzheimer'S Disease Neuroimaging Initiative
Open Access
- 3 April 2023
- journal article
- research article
- Published by Wiley in WIREs Computational Statistics
- Vol. 15 (5)
Abstract
Alzheimer's disease (AD) is a degenerative disorder involving significant memory loss and other cognitive deficits, manifesting as a progression from normal cognitive functioning to mild cognitive impairment to AD. The sooner an accurate diagnosis of probable AD is made, the easier it is to manage symptoms and plan for future therapy. Functional neuroimaging stands to be a useful tool in achieving early diagnosis. Among the many neuroimaging modalities, positron emission tomography (PET) provides direct regional assessment of, among others, brain metabolism, cerebral blood flow, amyloid deposition—all quantities of interest in the characterization of AD. However, there are analytic challenges in identifying early indicators of AD from these high‐dimensional imaging data sets, and it is unclear whether early indicators of AD are more likely to emerge in localized patterns of brain activity or in patterns of correlation between distinct brain regions. Early PET‐based analyses of AD focused on alterations in metabolic activity at the voxel‐level or in anatomically defined regions of interest. Other approaches, including seed‐voxel and multivariate techniques, seek to characterize metabolic connectivity by identifying other regions in the brain with similar patterns of activity across subjects. We briefly review various neuroimaging statistical approaches applied to determine changes in metabolic activity or metabolic connectivity associated with AD. We then present an approach that provides a unified statistical framework for addressing both metabolic activity and connectivity. Specifically, we apply a Bayesian spatial hierarchical framework to longitudinal metabolic PET scans from the Alzheimer's Disease Neuroimaging Initiative.This article is categorized under: Statistical and Graphical Methods of Data Analysis > Analysis of High Dimensional Data Statistical Learning and Exploratory Methods of the Data Sciences > Modeling Methods Statistical Models > Bayesian ModelsKeywords
Funding Information
- National Institute of Neurological Disorders and Stroke (P50NS123067)
- Alzheimer's Disease Neuroimaging Initiative
- National Institutes of Health (U01 AG024904)
- National Institute on Aging
This publication has 62 references indexed in Scilit:
- Longitudinal Progression of Cognitive Decline Correlates with Changes in the Spatial Pattern of Brain 18F-FDG PETJournal of Nuclear Medicine, 2013
- Resting metabolic connectivity in Alzheimer’s diseaseClinical and Translational Imaging, 2013
- Brodmann’s map of the human cerebral cortex — or Brodmann’s maps?Translational Neuroscience, 2012
- Multi-region analysis of longitudinal FDG-PET for the classification of Alzheimer's diseaseNeuroImage, 2012
- BSMac: A MATLAB toolbox implementing a Bayesian spatial model for brain activation and connectivityJournal of Neuroscience Methods, 2012
- Learning brain connectivity of Alzheimer's disease by sparse inverse covariance estimationNeuroImage, 2010
- Metabolic brain networks in neurodegenerative disorders: a functional imaging approachTrends in Neurosciences, 2009
- Principal component analysis in mild and moderate Alzheimer's disease — A novel approach to clinical diagnosisPsychiatry Research: Neuroimaging, 2009
- A Bayesian hierarchical framework for spatial modeling of fMRI dataNeuroImage, 2008
- Combining fMRI and SNP data to investigate connections between brain function and genetics using parallel ICAHuman Brain Mapping, 2007